All data are based on the daily closing price as of July 12, 2024
y

Yungjin Pharm.

003520.KO
1.63 USD
0.05
+3.16%

Overview

Last close
1.63 usd
Market cap
298.42M usd
52 week high
2.97 usd
52 week low
1.45 usd
Target price
N/A usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
2.3439
Price/Book Value
4.1524
Enterprise Value
308.38M usd
EV/Revenue
1.8257
EV/EBITDA
56.0608

Key financials

Revenue TTM
115.59M usd
Gross Profit TTM
50.07M usd
EBITDA TTM
10.54M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
173.67M usd
Net debt
N/A usd

About

Yungjin Pharm. Co., Ltd. operates as a pharmaceutical company in South Korea and internationally. It offers cephalosporin antibiotic, antipsychotic, cardiovascular, gastrointestinal, metabolic, neuropsychiatry, respiratory, infectious, anti-inflammatory and analgesics, nutritional supplement, and urology products. The company also provides vitamins, minerals, and other products; and APIs. Yungjin Pharm. Co., Ltd. was founded in 1952 and is headquartered in Seoul, South Korea. Yungjin Pharm. Co., Ltd. operates as a subsidiary of KT&G Corporation.
  • Symbol
    003520.KO
  • Exchange
    KO
  • Isin
    KR7003520004
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
  • Headquarter
    Seoul
  • Web site
    https://www.yungjin.co.kr
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top